INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit – HIMS GlobeNewswire August 16, 2025 SAN DIEGO, Aug. 16, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or […]

Empowering Art Narratives for Luxury Hospitality & Premium Commercial Interiors In the high-stakes world of custom artwork for luxury hotels and premium commercial spaces, owners and designers face fractured processes: disjointed art integration, budget overruns, and diluted cultural storytelling. For over 20 years, ZhengyinArt has pioneered end-to-end space art solutions, dismantling industry pain points through

(NASDAQ:CAPR), NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the “Class Period”), of the important September 15, 2025 lead plaintiff deadline. SO WHAT: If

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPR GlobeNewswire August 16, 2025 NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October

(NasdaqGM:RXST), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in RxSight between November 7, 2024 and July 8, 2025 and would like to discuss your legal rights, call Faruqi &

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight GlobeNewswire August 16, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in RxSight between November

NEW YORK CITY, NY / ACCESS Newswire / August 16, 2025 / WHY: New York, N.Y., August 16, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE:ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the

(NASDAQ:IRBT), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In iRobot To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in iRobot between January 29, 2024 and March 11, 2025 and would like to discuss your legal rights, call Faruqi &

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRobot Corporation GlobeNewswire August 16, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In iRobot To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in iRobot between

(NYSE:ANRO), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Alto To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Alto (a) Alto common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the